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ticriteria methods were chosen for comparison including:
Kepner-tregoe analysis (KTA), simple multi attribute rating tech-
nique (SMART), SMART using swing weights (SWING), Ana-
lytic Hierarchy Process (AHP) and Conjoint Analysis (CA). Four
attributes of treatment were identiﬁed (impact, duration, and
end-result of treatment and associated risks). Subjects were asked
to both rank and rate the importance of these attributes. After
using the methods to establish preferences for treatment, subjects
were asked to judge the overall difﬁculty of the techniques on
1–10 score, and answer questions regarding clarity of explana-
tion of method, difﬁculty in answering questions, understanding
method in relation to goal, and use of the method in health care
situations. Subjects were interviewed either once (n = 14) or
twice (n = 14) (Only the results of the ﬁrst measurement are pre-
sented) RESULTS: In the overall rating of methods CA scored
best (mean score 3.65), followed by SMART (3.70), AHP (4.00),
SWING (4.40) and KTA (4.67). CA also scored best on
verbal/written explanation, understanding of method in relation
to goal second and usefulness in health care situations, and
scored second place on difﬁculty in answering questions. In the
impaired population, AHP was rated best on the overall difﬁ-
culty score. CONCLUSIONS: In this pilot study, conjoint analy-
sis was the most preferred method of preference elicitation. Our
main concern regarding CA is the time it takes to ﬁll out a CA
questionnaire and the fact that data analysis is most complicated
of all methods included. Another concern regarding the use of
multicriteria methods needing further study is the rate of 
rank-reversal between methods in the cognitively impaired 
population.
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OBJECTIVE: To evaluate, in cases of ischemic vascular cerebral
disease (VCD), effectiveness in terms of functional recovery and
quality of life of an early hospital rehabilitation intervention with
follow-up in the patient’s home by a nursing team. Material and
METHODS: Patients with VCD >45 years of age were random-
ized for inclusion in an intervention program or control group.
The patients were selected from three Mexican Social Security
Institute (IMSS) hospitals in Mexico City between March 2003
and May 2004. The intervention consisted in a physical and social
rehabilitation program involving a nursing team which began in
the hospital and continued in the patient’s home; it had three
phases: a) intensive, with daily visits over 15 days, b) intermedi-
ate, with two weekly visits during the following two weeks, and
c) support, with a weekly visit over the following two months.
The control group received only information regarding VCD and
patient care and weekly visits. Barthel, Frenchay and SF 36 were
evaluated on admittance in hospital, and at 3 and 6 months after
discharge from hospital. RESULTS: Of a total of 187 patients
recruited, 90 completed the follow-up, 45 in group 1 (interven-
tion) and 44 in group 2 (control). Average age was similar in both
groups (72 years). Around 82% in both groups present chronic
disease. An increase of 43 points was observed in the Barthel
index at the end of the follow-up period for both groups (p =
0.21). General health was better at the end of the follow-up for
group 1 (p = 0.05). CONCLUSIONS: Early rehabilitation in hos-
pital with subsequent follow-up improves the perception the VCD
patient has of his/her health. It is also a useful support to the
patient’s functional recovery.
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OBJECTIVES: Diabetic peripheral neuropathy (DPN) results in
not only pain but a range of debilitating symptoms. The Neu-
ropathy Total Symptom Score 6 (NTSS-6 [self administered])
characterises the frequency and severity of the range DPN symp-
toms, the purpose of this study being to examine the inter-
association between symptoms. METHODS: A postal survey
using various instruments including the NTSS-6 was mailed to
subjects identiﬁed at random from hospital records as having
either type-1 or type-2 diabetes using the same methods as the
Health Outcomes Data Repository (HODaR). Cross-sectional
analysis was used to test for these inter-associations. This is a
preliminary analysis of the ﬁrst 604 returns. The NTSS-6 pro-
vides a score of 0 to 3.66 in each of 6 domains. The total score
(which can range from 0 to 21.96) is simply summed with zero
meaning no neuropathic symptoms. RESULTS: Of the 604
patients, 24% reported no symptoms; the characteristics of those
without and with DPN symptoms was: 58 vs. 64 years; males
56% vs. 60%; diabetes duration 16 vs. 13 years; history of car-
diovascular disease 31% vs. 50%; number of days in hospital in
the last year 3.4 vs. 7.7 days and 4.4 vs. 7.0 ambulatory care
attendances in the previous year, respectively. The proportion of
patients experiencing symptoms was for Aching, Prickling, Allo-
dynia (sensitivity), Numbness, Burning and Lancinating Pain:
62%, 58%, 46%, 44%, 42% and 39%, respectively. Multiple
combinations of symptoms occurred at the following rates: 11%
had one symptom type, 12% two, 12% three, 9% four, 12%
ﬁve and 21% all 6 symptoms. CONCLUSIONS: DPN has a
range of debilitating symptoms, although there is a tendency to
focus on pain. DPN symptoms occur frequently, in combination
and one ﬁfth of respondents reported experiencing all six cate-
gories of symptoms.
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